Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity
- DOI
- 10.3389/fimmu.2024.1505752
- Published
- 2025-01-06
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2024.1505752,
title = {Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity},
author = {Stephane Isnard and Tsoarello Mabanga and Léna Royston and Carolina A. Berini and Simeng Bu and Orthy Aiyana and Hansen Feng and Bertrand Lebouché and Cecilia T. Costiniuk and Joseph Cox and Guido Kroemer and Madeleine Durand and Jean-Pierre Routy and Unknown},
year = {2025},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2024.1505752},
url = {https://doi.org/10.3389/fimmu.2024.1505752}
}RIS
TY - JOUR TI - Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity AU - Stephane Isnard AU - Tsoarello Mabanga AU - Léna Royston AU - Carolina A. Berini AU - Simeng Bu AU - Orthy Aiyana AU - Hansen Feng AU - Bertrand Lebouché AU - Cecilia T. Costiniuk AU - Joseph Cox AU - Guido Kroemer AU - Madeleine Durand AU - Jean-Pierre Routy AU - Unknown PY - 2025 JO - Frontiers in Immunology DO - 10.3389/fimmu.2024.1505752 UR - https://doi.org/10.3389/fimmu.2024.1505752 ER -
APA
Isnard, S., Mabanga, T., Royston, L., Berini, C. A., Bu, S., Aiyana, O., Feng, H., Lebouché, B., Costiniuk, C. T., Cox, J., Kroemer, G., Durand, M., Routy, J., & Unknown (2025). Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1505752
Source records
- crossref · retrieved 2026-09-26T09:39:33.796Z